Article
Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
Genes, chromosomes & cancer - 1 Jun 2021
Orsmark-Pietras Christina, Landberg Niklas, Lorenz Fryderyk, Uggla Bertil, Höglund Martin, Lehmann Sören, Derolf Åsa, Deneberg Stefan, Antunovic Petar, Cammenga Jörg, Möllgård Lars, Wennström Lovisa, Lilljebjörn Henrik, Rissler Marianne, Fioretos Thoas, Lazarevic Vladimir Lj
Abstract excerpt
Acute myeloid leukemia (AML) with t(9;22)(q34;q11), also known as AML with BCR-ABL1, is a rare, provisional entity in the WHO 2016 classification and is considered a high-risk disease according to the European LeukemiaNet 2017 risk stratification. We here present a retrospective, population-based study of this disease entity from the Swedish Acute Leukemia Registry. By strict clinical inclusion criteria we aimed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.